CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

PR Newswire Clinical Trials
Original article

Texas Cardiac Arrhythmia Institute at St. David's Medical Center first in U.S. to participate in trial for innovative mapping and pulsed field ablation system

Trial StartNext-generation mapping and pulsed field ablation systemPositive
AI Analysis

Summary

Texas Cardiac Arrhythmia Institute became the first U.S. facility to participate in a clinical trial evaluating a next-generation mapping and pulsed field ablation system for cardiac arrhythmia treatment.

Clinical Trial Data

Importance:3/10
Sentiment:
0.30
clinical_trialcardiologyablation_systemfirst_in_nation
Related Companies

Read the original article

Published by PR Newswire Clinical Trials on September 2, 2026 1:37 PM

Read Original